ArticleEClinicalMedicine2024

Safety and efficacy of ixoberogene soroparvovec in neovascular age-related macular degeneration in the United States (OPTIC): a prospective, two-year, multicentre phase 1 study.

Arshad M Khanani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.